Contact
    Start Publications A Tenon's capsule/bulbar conjunctiva interface biomimetic to ...
    ←  Publication Finder
    Attension

    A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery

    Year: 2020

    Journal: PLoS One, Volume 15, NOV 3

    Authors: Kozdon, Katarzyna; Caridi, Bruna; Duru, Iheukwumere; Ezra, Daniel G.; Phillips, James B.; Bailly, Maryse

    Organizations: Moorfields Eye Charity [ST 12 11 B]; Department of Health by the National Institute for Health Research; UCL Institute of Ophthalmology for a Biomedical Research Centre for Ophthalmology

    Glaucoma filtration surgery is one of the most effective methods for lowering intraocular pressure in glaucoma. The surgery efficiently reduces intra-ocular pressure but the most common cause of failure is scarring at the incision site. This occurs in the conjunctiva/Tenon's capsule layer overlying the scleral coat of the eye. Currently used antimetabolite treatments to prevent post-surgical scarring are non-selective and are associated with potentially blinding side effects. Developing new treatments to target scarring requires both a better understanding of wound healing and scarring in the conjunctiva, and new means of delivering anti-scarring drugs locally and sustainably. By combining plastic compression of collagen gels with a soft collagen-based layer, we have developed a physiologically relevant model of the sub-epithelial bulbar conjunctiva/Tenon's capsule interface, which allows a more holistic approach to the understanding of subconjunctival tissue behaviour and local drug delivery. The biomimetic tissue hosts both primary human conjunctival fibroblasts and an immune component in the form of macrophages, morphologically and structurally mimicking the mechanical proprieties and contraction kinetics of ex vivo porcine conjunctiva. We show that our model is suitable for the screening of drugs targeting scarring and/or inflammation, and amenable to the study of local drug delivery devices that can be inserted in between the two layers of the biomimetic. We propose that this multicellular-bilayer engineered tissue will be useful to study complex biological aspects of scarring and fibrosis, including the role of inflammation, with potentially significant implications for the management of scarring following glaucoma filtration surgery and other anterior ocular segment scarring conditions. Crucially, it uniquely allows the evaluation of new means of local drug delivery within a physiologically relevant tissue mimetic, mimicking intraoperative drug delivery in vivo.
    View publication